OXiGENE Announces Year-End 2012 Earnings Conference Call and Webcast
SOUTH SAN FRANCISCO, Calif., March 4, 2013 (GLOBE NEWSWIRE) -- OXiGENE, Inc.
(Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel
therapeutics to treat cancer, will report year-end 2012 results on Tuesday,
March 12, 2013. A conference call and webcast hosted by OXiGENE management
will begin at 4:30 pm ET (1:30 p.m. PT).
OXiGENE's earnings conference call can be heard live by dialing (888) 841-3431
in the United States and Canada, and +1 (678) 809-1060 for international
callers, five minutes prior to the beginning of the call.
To listen to a live or archived version of the audio webcast, please log on to
the Company's website, www.oxigene.com. Under the "Investors" tab, select the
link to "Events & Presentations."
OXiGENE is a clinical-stage biopharmaceutical company developing novel
therapeutics to treat cancer. The Company's major focus is developing vascular
disrupting agents that selectively disrupt abnormal blood vessels associated
with solid tumor progression. OXiGENE is dedicated to leveraging its
intellectual property and therapeutic development expertise to bring
life-extending and life-enhancing medicines to patients.
The OXiGENE, Inc. logo is available at
CONTACT: Investor and Media Contact:
Press spacebar to pause and continue. Press esc to stop.